|

Galcanezumab Clinical Trials

2 actively recruiting trials

Also known as: Emgality, Emgality®

Pipeline

Early 1: 1

Top Sponsors

  • Xuanwu Hospital, Beijing1
  • Medical University of Vienna1

Indications

  • Episodic Migraine1
  • Alzheimer's Disease1
  • Chronic Migraine1
  • Depression1
  • Anxiety1

Other2 trials

CGRP Inhibition, Autonomic Function, and Migraine
Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.